Wilson disease: description of 282 patients evaluated over 3 decades.
about
Biomarkers for diagnosis of Wilson's diseaseNeuroferritinopathy: Pathophysiology, Presentation, Differential Diagnoses and ManagementCopper signaling in the mammalian nervous system: synaptic effectsSecondary psychosis induced by metabolic disordersInteractions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's diseaseA review and current perspective on Wilson disease.Do cytokines have any role in Wilson's disease?Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review.Undulating tongue in Wilson's diseaseEstrogen intake and copper depositions: implications for Alzheimer's disease?Clinical application of liver MR imaging in Wilson's disease.Bipolar disorders and Wilson's disease.Wilson disease: Canadian perspectives on presentation and outcomes from an adult ambulatory setting.Sleep in Wilson's disease: Questionnaire based studyWilson's disease and other neurological copper disorders.Wilson's Disease in Bangladeshi Children: Analysis of 100 CasesFourteen Years of Experience of Liver Transplantation for Wilson's Disease; a Report on 107 Cases from Shiraz, IranClinical features and outcome in patients with osseomuscular type of Wilson's disease.Wilson's disease: A review of what we have learned.A genetic study of Wilson's disease in the United KingdomMetal-induced neurodegeneration in C. elegans.Current Drug Managements of Wilson's Disease: From West to East.P wave dispersion is prolonged in patients with Wilson's disease.Cardiac arrhythmia in Wilson's disease: An oversighted and overlooked entity!Multifocal myoclonus as a heralding manifestation of Wilson disease.Presentation of Epilepsy in a Patient with Wilson's Disease and Developmental Venous Anomaly (Venous Angioma) in the BrainTreatment of Wilson's disease motor complications with deep brain stimulation.Dystonia in children and adolescents: a systematic review and a new diagnostic algorithm.Protecting the mitochondrial powerhouse.A novel diagnostic approach to patients with myoclonus.MR imaging features of focal liver lesions in Wilson disease.Copper increases the ability of 6-hydroxydopamine to generate oxidative stress and the ability of ascorbate and glutathione to potentiate this effect: potential implications in Parkinson's disease.Psychiatric comorbidity in Wilson's disease.Copper dopamine complex induces mitochondrial autophagy preceding caspase-independent apoptotic cell death.Homozygosity for Non-H1069Q Missense Mutations in ATP7B Gene and Early Severe Liver Disease: Report of Two Families and a Meta-analysis.The genetics of Wilson disease.Oral complications associated with D-penicillamine treatment for Wilson disease: a clinicopathologic report.Insights into the management of Wilson's disease.The optimal threshold of serum ceruloplasmin in the diagnosis of Wilson's disease: A large hospital-based study.Do MRI features distinguish Wilson's disease from other early onset extrapyramidal disorders? An analysis of 100 cases.
P2860
Q26471573-0B20337D-63BC-453D-8649-17F9B998D102Q26749945-D8834856-621E-4072-8EA8-5471E8B4E2B7Q26849773-77063CA0-56EC-41E3-A625-7A050DA02764Q27015730-BBEB7B35-B89E-4D5F-BDD4-A135F8299F5EQ28391762-F78ECA4A-C72E-4E51-8DD2-3754C5A951F6Q30907824-EFF5F060-17DC-4FE9-B44D-A56134532791Q33381318-DB42F470-C2E5-481A-B1B6-8C00D0C8AE7DQ33707443-6F84752A-4286-4D8F-AA2E-5D37BF6F7F0CQ33877864-C03348B3-A904-438A-8CCB-0F325F5AB320Q33929847-5A05B430-E394-450A-9510-2E3D4B3C1D20Q34280752-FB1C82E6-E53C-44D2-8164-F3912AA26CF1Q34286377-601ABFFC-D743-41B3-B4E0-CA494E74B04AQ34312473-CC902C8E-F57E-48AB-84BB-3EB55691E173Q34994088-5B794062-ABE8-4745-BB5F-60C1F6FDEF52Q35106874-4D910486-8C58-48CF-ACAC-FBD4D2F9A731Q35823693-40BA7435-0C08-4B5F-A4AB-2CA9ABA1714CQ36216217-85CA1D5E-3A8D-42DF-8F8C-8697160279EAQ36284356-CF5FA224-F972-4DD5-83FD-14E7668DED8AQ36369817-CABAEFE9-6A41-4DA2-8D5E-700125F7EC19Q36789573-39FC57CD-EF4C-4BE0-A417-AB450CC21F44Q36854442-1B5D3A6B-AD41-4335-8074-614CFBFB8DD3Q36925896-6E8DA0BF-B4EC-4FE7-AAC1-DE8BD16E1ED7Q37212956-5D126A9C-238E-47E6-A28A-4F5A24B0387FQ37221186-481FE5C9-B39B-4570-B5FC-6573D5A31B99Q37649584-F32B78E9-D860-4752-B8F2-4B62B6BBDC8AQ38070404-31E45A1A-5104-4473-80BC-B4C4FA242414Q38189115-527B962D-B9B0-44D5-AF25-B056FFFF98F2Q38268070-4D4E9F82-B78D-47DC-A1B0-3D681F4C161CQ38286869-C9C71013-5D28-49D6-84EC-8AB49C9481E0Q38629335-3262C2D0-B0DD-4CCB-8414-43597B63DA8CQ38817986-E915E80D-76F3-479C-8E84-8909293FE8B3Q38907596-5C8B54EE-C05A-41C5-9F1F-9AE7B818D822Q39417676-A9B4BB35-8251-4B85-9404-8C2511E815A8Q39876387-69D81DEF-7F01-4FF9-8AA4-7C0EBD5C66B4Q42368187-59622793-CFB2-402A-9542-AE187E9E6049Q42380502-3ADA1687-56D0-45DE-AA8B-90060DD3D6EDQ43103023-1DE883C6-1A09-4ECA-8FA6-8F2D0168FDA2Q47105991-1B202CCD-B82F-4540-8AF5-E1E2A00CDA00Q48259860-200D6DEF-0303-4041-AAB6-C2654CB046DAQ51851877-43302158-2A0B-4363-A190-C7E6502CF73A
P2860
Wilson disease: description of 282 patients evaluated over 3 decades.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Wilson disease: description of 282 patients evaluated over 3 decades.
@en
Wilson disease: description of 282 patients evaluated over 3 decades.
@nl
type
label
Wilson disease: description of 282 patients evaluated over 3 decades.
@en
Wilson disease: description of 282 patients evaluated over 3 decades.
@nl
prefLabel
Wilson disease: description of 282 patients evaluated over 3 decades.
@en
Wilson disease: description of 282 patients evaluated over 3 decades.
@nl
P2093
P1433
P1476
Wilson disease: description of 282 patients evaluated over 3 decades.
@en
P2093
Arun B Taly
G R Arunodaya
S Meenakshi-Sundaram
Sanjib Sinha
P304
P356
10.1097/MD.0B013E318045A00E
P407
P577
2007-03-01T00:00:00Z